Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Factors in Schizophrenia: Mechanisms and Experimental Approaches
Melanie Föcking, Benjamin Doyle, Nayla Munawar, et al.
Complex Psychiatry (2019) Vol. 5, Iss. 1, pp. 6-12
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
María S. García‐Gutiérrez, Francisco Navarrete, F. Sala, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 242
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 64
Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?
Nayla Munawar, Khansa Ahsan, Khalid Muhammad, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7671-7671
Open Access | Times Cited: 72
MIAT LncRNA: A multifunctional key player in non-oncological pathological conditions
Yousra Zeinelabdeen, Tasneem Abaza, Montaser Bellah Yasser, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 447-462
Open Access | Times Cited: 9
A Neurodevelopment Approach for a Transitional Model of Early Onset Schizophrenia
Domenico De Berardis, Sergio De Filippis, Gabriele Masi, et al.
Brain Sciences (2021) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 49
Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients
Ebubekir Dirican, Halil Özcan, Sevgi Karabulut Uzunçakmak, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 1, pp. 171-178
Open Access | Times Cited: 23
Epigenetics of Ageing and Psychiatric Disorders
Cezar-Ivan Coliță, Ion Udriștoiu, Diana–Larisa Ancuta, et al.
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 1, pp. 13-13
Open Access | Times Cited: 6
Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort
Mohammad Shboul, Amal Bani Domi, A. Zahra, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 350-358
Open Access | Times Cited: 5
Genetic overlap between schizophrenia and cognitive performance
Jianfei Zhang, Hao Qiu, Qiyu Zhao, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia
Oihane Martínez-Peula, Benito Morentín, Luís F. Callado, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 1, pp. E35-E44
Open Access | Times Cited: 4
Novel Insights into Psychosis and Antipsychotic Interventions: From Managing Symptoms to Improving Outcomes
Adonis Sfera, Hassan Imran, Dan O. Sfera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5904-5904
Open Access | Times Cited: 4
Exploring Potential Medications for Alzheimer’s Disease with Psychosis by Integrating Drug Target Information into Deep Learning Models: A Data-Driven Approach
Oshin Miranda, Chen Jiang, Xiguang Qi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1617-1617
Open Access
Epigenetic Insights into Substance Use Disorder and Associated Psychiatric Conditions
A. Ngo, Christopher M Ahmad, Niki Gharavi Alkhansari, et al.
Complex Psychiatry (2025) Vol. 11, Iss. 1, pp. 12-36
Closed Access
The Role and Importance of Neuroinflammation in Biopsychiatry
Hayriye Soytürk, Ümit Kılıç, Cansu Önal, et al.
IntechOpen eBooks (2025)
Closed Access
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
Oliwia Koszła, Katarzyna M. Targowska‐Duda, Ewa Kędzierska, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 160-160
Open Access | Times Cited: 21
Genome-wide DNA methylation profiling in anorexia nervosa discordant identical twins
Carmen Iranzo-Tatay, David Hervás, Luis Miguel Rojo-Bofill, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Untangling Depression in Schizophrenia: The Role of Disorganized and Obsessive-Compulsive Symptoms and the Duration of Untreated Psychosis
Georgi Panov, Silvana Dyulgerova, Presyana Panova, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2646-2646
Open Access | Times Cited: 2
The clues in solving the mystery of major psychosis: The epigenetic basis of schizophrenia and bipolar disorder
Çevik Gürel, Gökçe Ceren Kuşçu, Altuğ Yavaşoğlu, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 113, pp. 51-61
Closed Access | Times Cited: 18
Neuronal Lhx1 expression is regulated by DNMT1-dependent modulation of histone marks
Judit Symmank, Cathrin Bayer, Julia Reichard, et al.
Epigenetics (2020) Vol. 15, Iss. 11, pp. 1259-1274
Open Access | Times Cited: 18
Contribution of Human Pluripotent Stem Cell-Based Models to Drug Discovery for Neurological Disorders
Alexandra Benchoua, Marie Lasbareilles, Johana Tournois
Cells (2021) Vol. 10, Iss. 12, pp. 3290-3290
Open Access | Times Cited: 10
Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations
Jacob D. Clarin, Nadia N. Bouras, Wen‐Jun Gao
Genes (2024) Vol. 15, Iss. 9, pp. 1214-1214
Open Access | Times Cited: 1
A comprehensive framework for trans-ancestry pathway analysis using GWAS summary data from diverse populations
Sheng Fu, William Wheeler, Kevin Wang, et al.
PLoS Genetics (2024) Vol. 20, Iss. 10, pp. e1011322-e1011322
Open Access | Times Cited: 1
mTOR Expression in Hippocampus and Prefrontal Cortex Is Downregulated in a Rat Model of Schizophrenia Induced by Chronic Administration of Ketamine
Runfang Xie, Jiming Xie, Yi Ye, et al.
Journal of Molecular Neuroscience (2020) Vol. 70, Iss. 2, pp. 269-275
Closed Access | Times Cited: 9
Third-generation genome sequencing implicates medium-sized structural variants in chronic schizophrenia
Chi Chiu Lee, Rui Ye, Justin D. Tubbs, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 3
Improving Therapeutic Interventions of Schizophrenia with Advances in Stem Cell Technology
José Espejo
Clinical Psychopharmacology and Neuroscience (2020) Vol. 18, Iss. 3, pp. 352-361
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top